The NCCN Guidelines for Prostate Cancer Early Detection provide recommendations for men choosing to participate in an early detection program for prostate cancer. These NCCN Guidelines Insights highlight notable recent updates.

Join Philip Kantoff, MD, and Paul Nguyen, MD, as they present their multidisciplinary expertise on a range of cases pertaining to prostate cancer.

Neuroendocrine prostate cancer (NEPC) encompasses various clinical contexts, ranging from the de novo presentation of small cell prostatic carcinoma to a treatment-emergent transformed phenotype that arises from typical adenocarcinoma of the prostate.

Join Philip Kantoff, MD, and Paul Nguyen, MD, as they present their multidisciplinary expertise on a range of cases pertaining to prostate cancer.

The NCCN Guidelines for Prostate Cancer provide multidisciplinary recommendations on the clinical management of patients with prostate cancer. This report highlights notable recent updates.

The 2013 NCCN Case Manager Webinar Series consists of six activities on the topics of Acute Lymphocytic Leukemia (ALL), Biomarkers, Colorectal Cancer, Metastatic Prostate Cancer, Multiple Myeloma, and Palliative Care.

The NCCN Guidelines are continuously updated to reflect the newest standards of care in oncology.

The 2013 NCCN Case Manager Webinar Series will consist of six live webinars on the topics of Acute Lymphocytic Leukemia (ALL), Biomarkers, Colorectal Cancer, Metastatic Prostate Cancer, Multiple Myeloma, and Palliative Care.

Prostate cancer is the most common noncutaneous cancer among men. This case report describes a 43-year-old man with rapidly progressing castration-resistant prostate cancer (CRPC) that failed to respond to docetaxel and cabazitaxel.

The 2013 Nursing Program: Advancing Oncology Nursing™ webinar series provides the oncology nurse with comprehensive and clinically relevant information regarding the management of patients with cancer.